Prelude Capital Management’s Nightstar Therapeutics plc American Depositary Shares NITE Stock Holding History

Prelude Capital Management’s Portfolio NITE Stock Details NITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-9,410	Closed	-$239K	–	2363
2019 Q1	$239K	Buy	+9,410	New	+$166K	0.01%	662
2018 Q4	–	Sell	-2,173	Closed	-$44K	–	2370
2018 Q3	$44K	Sell	2,173 -31,996	-94%	-$657K	﹤0.01%	1162
2018 Q2	$547K	Hold	34,169	–	–	0.03%	511
2018 Q1	$489K	Hold	34,169	–	–	0.04%	446
2017 Q4	$448K	Sell	34,169 -32,164	-48%	-$578K	0.04%	449
2017 Q3	$1.27M	Buy	+66,333	New	+$1.43M	0.11%	194

Prelude Capital Management's NITE Position: Q2 2019 in Review

Prelude Capital Management sold out of Nightstar Therapeutics plc American Depositary Shares (NITE) in Q2 2019, closing a stake of 9,410 shares — an estimated $239K sold.

Prelude Capital Management first reported a position in NITE in Q3 2017 and held it in 6 quarters. The position peaked at $1.27M in Q3 2017. 0 funds tracked by Wall St. Rank hold NITE as of Q2 2019.

Prelude Capital Management reported no remaining Nightstar Therapeutics plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Prelude Capital Management sold 9,410 Nightstar Therapeutics plc American Depositary Shares shares in Q2 2019, an estimated $239K.
Prelude Capital Management first reported a position in Nightstar Therapeutics plc American Depositary Shares in Q3 2017 and held it in 6 quarters.
Prelude Capital Management's Nightstar Therapeutics plc American Depositary Shares position peaked at $1.27M in Q3 2017.
0 funds tracked by Wall St. Rank held Nightstar Therapeutics plc American Depositary Shares as of Q2 2019.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.